HHSN27200037

IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINE

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	NATIONAL INSTITUTES OF HEALTH NIAID
NAICS	541712
PSC	AN86 — AIDS RESEARCH - MANAGEMENT AND SUPPORT
Parent award / vehicle	HHSN272201100021I
Set-aside	Not reported
Pricing type	COST PLUS FIXED FEE
Obligations	$4.4M
Current contract value	$4.4M
Potential contract value / ceiling	$4.4M
Start date	Sep 15, 2016
Current end date	Sep 30, 2028
Potential end date	Sep 30, 2028
Latest award activity	Dec 19, 2024
Source loaded	Sep 26, 2026

Funding and modification history

Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Dec 19, 2024	P00007	$0	THIS TASK ORDER IS FOR THE CURRENT GOOD MANUFACTURING PRACTICE (CGMP) MANUFACTURE OF A RECOMBINANT NON-REPLICATING SIMIAN (CHIMPANZEE) ADENOVIRUS (CHADOX1.THIVCONSV6) HIV-1 VACCINE FOR USE IN HUMAN CLINICAL TRIALS.
Dec 18, 2024	P00006	$0	THIS TASK ORDER IS FOR THE CURRENT GOOD MANUFACTURING PRACTICE (CGMP) MANUFACTURE OF A RECOMBINANT NON-REPLICATING SIMIAN (CHIMPANZEE) ADENOVIRUS (CHADOX1.THIVCONSV6) HIV-1 VACCINE FOR USE IN HUMAN CLINICAL TRIALS.
May 15, 2024	P00005	$331.1K	THIS TASK ORDER IS FOR THE CURRENT GOOD MANUFACTURING PRACTICE (CGMP) MANUFACTURE OF A RECOMBINANT NON-REPLICATING SIMIAN (CHIMPANZEE) ADENOVIRUS (CHADOX1.THIVCONSV6) HIV-1 VACCINE FOR USE IN HUMAN CLINICAL TRIALS.
Jun 23, 2022	P00004	$115.5K	THIS TASK ORDER IS FOR THE CURRENT GOOD MANUFACTURING PRACTICE (CGMP) MANUFACTURE OF A RECOMBINANT NON-REPLICATING SIMIAN (CHIMPANZEE) ADENOVIRUS (CHADOX1.THIVCONSV6) HIV-1 VACCINE FOR USE IN HUMAN CLINICAL TRIALS.
Jun 30, 2021	P00003	$0	THIS TASK ORDER IS FOR THE CURRENT GOOD MANUFACTURING PRACTICE (CGMP) MANUFACTURE OF A RECOMBINANT NON-REPLICATING SIMIAN (CHIMPANZEE) ADENOVIRUS (CHADOX1.THIVCONSV6) HIV-1 VACCINE FOR USE IN HUMAN CLINICAL TRIALS.
Nov 15, 2019	P00002	$0	ADMINISTRATIVE MODIFICATION
Aug 9, 2019	P00001	$2.1M	R&D- MEDICAL: AIDS RESEARCH (MANAGEMENT/SUPPORT)
Sep 15, 2016	0	$1.9M	IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINE

Estimated positioning window

Sep 30, 2027 – Mar 30, 2028

Recompete signal:

60/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 60/100. Available recorded signals: 55 points.

Contract end 2028-09-30 (699 days from calculation): +25 points
13 historical awards in this buyer and category group: +15 points
8 recorded award transactions: +10 points
Latest award action: 2024-12-19: +0 points
Parent award identifier recorded: +5 points
Solicitation identifier recorded: +0 points
Linked official forecast: +0 points
Calculated on: 2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Confirm the ordering vehicle and your eligibility or a qualified teaming route.
Review the award scope and buyer evidence before making a bid/no-bid decision.